Algorithm-based prevention and reduction of cancer health disparity arising from data inequality
Algorithm-based prevention and reduction of cancer health disparity arising from data inequality
批准号:
10673024
负责人:
YAN CUI
金额:
$34.52万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-08-31
关键词:
AddressAffectAfrican American populationAlgorithmsArchivesArtificial IntelligenceAsian populationBenchmarkingBiomedical ResearchCaucasiansClinicalClinical ResearchCodeCohort StudiesComputing MethodologiesDataData SetDatabasesDiagnosisDisadvantagedDisadvantaged minorityDisparityDistantEthnic OriginEthnic PopulationEuropean ancestryGenomicsGenotypeGoalsHealthcare SystemsHispanic PopulationsIndividualInequalityInternetKnowledgeKnowledge ManagementLearningMachine LearningMalignant NeoplasmsMedical GeneticsMinority GroupsModelingMultiomic DataOutcomePerformancePopulationPredictive AnalyticsPreventionPrognosisRaceReduce health disparitiesResearchResearch Project GrantsResourcesRetrievalSamplingSchemeSystemTestingThe Cancer Genome AtlasTherapeuticTrainingWorkbasecancer genomicscancer health disparitycancer riskcancer subtypescancer typecohortdatabase of Genotypes and Phenotypesdisorder riskethnic disparityethnic diversityethnic minorityethnic minority populationexperimental studygenetic architecturegenome wide association studygenomic datahealth disparityimprovedinnovationknowledgebasemachine learning methodmachine learning modelmulti-ethnicphenotypic dataprecision medicinepreventracial populationresearch studyresponsesecondary analysisself-directed learningstatisticstransfer learninguser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ethnic minority groups have a long-term cumulative data disadvantage in biomedical research and clinical
studies. Statistics have shown that over 90% of the samples in cancer-related GWAS and clinical omics projects
were collected from Individuals of European ancestry. This severe data disadvantage of the ethnic minority
groups is set to produce new health disparities as data-driven, algorithm-based biomedical research and clinical
decisions become increasingly common. The new cancer disparity arising from data inequality can potentially
impact all ethnic minority groups in all types of cancers where data inequality exists. Thus, its negative impact is
not limited to the cancer types or subtypes for which significant ethnic disparities have already been evident. The
long-term goal of the proposed research is to prevent or reduce the heath disparities arising from the data
disadvantage of ethnic minority groups. The overall objective of this work is to obtain key knowledge and create
open resources to establish a new paradigm for machine learning with multiethnic clinical omics data. Our central
hypothesis is that the knowledge learned from data of the majority population can be transferred to improve
machine learning performance on the data-disadvantaged ethnic minority groups. Guided by strong preliminary
data, we will pursuit two specific aims to 1) Discover from cancer clinical omics data and genotype-phenotype
data: under what conditions and to what extent the transfer learning scheme improves machine learning model
performance on data-disadvantaged ethnic minority groups; 2) Create an open resource system for unbiased
multiethnic machine learning to prevent or reduce new health disparities arising from the data disadvantage of
ethnic minorities. The approach is innovative because it represents a substantive departure from the status quo
by shifting the paradigm of multiethnic machine learning from mixture learning and independent learning
schemes to a transfer learning scheme. The proposed research is significant, because it is expected to establish
a new paradigm for unbiased multiethnic machine learning and to provide an open resource system to facilitate
the paradigm shift, and thus to prevent or reduce health disparities arising from the data disadvantage of ethnic
minorities.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1146/annurev-biodatasci-020722-020704
发表时间:
2023-08-10
期刊:
Annual review of biomedical data science
影响因子:
--
作者:
[]
通讯作者:
Clinical time-to-event prediction enhanced by incorporating compatible related outcomes.
通过纳入兼容的相关结果来增强临床事件发生时间预测。
DOI:
10.1371/journal.pdig.0000038
发表时间:
2022
期刊:
PLOS digital health
影响因子:
--
作者:
[Gao,Yan, Cui,Yan]
通讯作者:
Cui,Yan
Targeting the CD73-adenosinergic pathway in head and neck cancer
-
批准号:10813613
-
项目类别:
-
资助金额:$68.61万
-
财政年份:2023
-
负责人:YAN CUI
-
依托单位:
Algorithm-based prevention and reduction of cancer health disparity arising from data inequality
-
批准号:10275989
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2021
-
负责人:YAN CUI
-
依托单位:
CD73 expression on cancer-associated fibroblasts of Head and Neck Cancers shapes the immune landscape
-
批准号:9912757
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2019
-
负责人:YAN CUI
-
依托单位:
P53 inactivation on MDSC development and tumor progression
-
批准号:9248356
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2013
-
负责人:YAN CUI
-
依托单位:
P53 inactivation on MDSC development and tumor progression
-
批准号:8577716
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2013
-
负责人:YAN CUI
-
依托单位:
P53 inactivation on MDSC development and tumor progression
-
批准号:8868065
-
项目类别:
-
资助金额:$31.51万
-
财政年份:2013
-
负责人:YAN CUI
-
依托单位:
P53 inactivation on MDSC development and tumor progression
-
批准号:8692674
-
项目类别:
-
资助金额:$30.36万
-
财政年份:2013
-
负责人:YAN CUI
-
依托单位:
In vivo targeted DC vaccine to activate anti-tumor CTL
-
批准号:7913511
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2009
-
负责人:YAN CUI
-
依托单位:
OVERCOMING TUMOR TOLERANCE THROUGH IN VIVO GENERATED DENDRITIC CELLS
-
批准号:7720483
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2008
-
负责人:YAN CUI
-
依托单位:
LSUHSC COBRE:PROJ 2: OVERCOMING TUMOR TOLER THROUGH IN VIVO GEN* DENDRITIC CELLS
-
批准号:7610786
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2007
-
负责人:YAN CUI
-
依托单位:
LSUHSC COBRE:PROJ 2: OVERCOMING TUMOR TOLER THROUGH IN VIVO GEN* DENDRITIC CELLS
-
批准号:7382264
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2006
-
负责人:YAN CUI
-
依托单位:
In vivo targeted DC vaccine to activate anti-tumor CTL
-
批准号:7082897
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2005
-
负责人:YAN CUI
-
依托单位:
In vivo targeted DC vaccine to activate anti-tumor CTL
-
批准号:6979942
-
项目类别:
-
资助金额:$25.42万
-
财政年份:2005
-
负责人:YAN CUI
-
依托单位:
In vivo targeted DC vaccine to activate anti-tumor CTL
-
批准号:7230443
-
项目类别:
-
资助金额:$10.83万
-
财政年份:2005
-
负责人:YAN CUI
-
依托单位:
In vivo targeted DC vaccine to activate anti-tumor CTL
-
批准号:7250352
-
项目类别:
-
资助金额:$8.81万
-
财政年份:2005
-
负责人:YAN CUI
-
依托单位:
In vivo targeted DC vaccine to activate anti-tumor CTL
-
批准号:7424927
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2005
-
负责人:YAN CUI
-
依托单位:
In vivo targeted DC vaccine to activate anti-tumor CTL
-
批准号:7602964
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2005
-
负责人:YAN CUI
-
依托单位:
LSUHSC COBRE:PROJ 2: OVERCOMING TUMOR TOLERANCE
-
批准号:7171450
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2005
-
负责人:YAN CUI
-
依托单位:
海外基金